Presidential Advisory Council on Combating Antibiotic-Resistant Bacteria (PACCARB)

The Presidential Advisory Council on Combating Antibiotic-Resistant Bacteria—which includes Dr. Beth Bell, Director of the National Center for Emerging and Zoonotic Infectious Diseases at CDC, as a non-voting member—is comprised of human and animal health experts who will provide advice, information, and recommendations to the Health and Human Services (HHS) Secretary on federal programs and policies related to combating antibiotic-resistant bacteria.

Tackling antibiotic resistance requires a coordinated approach across industries and nations. The Advisory Council works together to ensure the continued effectiveness of antibiotics and slow the threat of resistant germs for the future by complementing progress made in other federal efforts, specifically the National Action Plan for Combating Antibiotic-Resistant Bacteria [63 pages]

CDC appreciates the members of the Advisory Council for their willingness to serve in the fight against one of the biggest public health problems facing our world today.

Chair: Martin J. Blaser, M.D.; Muriel and George Singer Professor of Medicine, Professor of Microbiology, and Director of the Human Microbiome Program, NYU School of Medicine, New York City.

Vice Chair: Lonnie J. King, D.V.M., M.S., M.P.A., A.C.V.P.M.; Dean, College of Veterinary Medicine, Executive Dean, Health Science Colleges, Ohio State University, Columbus, Ohio.

Michael Apley, D.V.M., Ph.D., D.A.C.V.C.P.; Professor, Department of Clinical Sciences, Kansas State University College of Veterinary Medicine, Manhattan, Kansas.

Helen Boucher, M.D., F.A.C.P., F.I.D.S.A.; Director, Infectious Diseases Fellowship Program and Associate Professor of Medicine, Tufts University School of Medicine, Boston, Massachusetts.

Angela Caliendo, M.D., Ph.D., F.I.D.S.A.; Professor and Executive Vice Chair of Medicine and Director of the Division of General Internal Medicine, Alpert Medical School of Brown University, Providence, Rhode Island.

Alicia R. Cole; Founder, Alliance for Safety Awareness for Patients (ASAP), Sherman Oaks, California.

Sara Cosgrove, M.D., M.S.; Director, Antimicrobial Stewardship Program, The Johns Hopkins Hospital, and Associate Professor of Medicine, Division of Infectious Diseases, Johns Hopkins University School of Medicine, and Department of Epidemiology, Johns Hopkins University Bloomberg School of Public Health, Baltimore.

Peter Robert Davies, B.V.Sc., Ph.D.; Professor of Swine Health and Production, University of Minnesota, Minneapolis.

Kent E. Kester, M.D., F.A.C.P., F.I.D.S.A., F.A.S.T.M.H.; Vice President and Head, Translational Sciences and Biomarkers, Sanofi Pasteur, Swiftwater, Pennsylvania.

Ramanan Laxminarayan, Ph.D., M.P.H; Director and Senior Fellow, Center for Disease Dynamics, Economics and Policy, Washington, D.C.

Aileen M. Marty, M.D., F.A.C.P.; Professor, Infectious Diseases, Department of Medicine, Family Medicine, and Community Health, Director, Health Travel Medicine Program and Vaccine Clinic, Florida International University, Miami.

John H. Rex, M.D.; Senior Vice President and Head of Infection, Global Medicines Development, AstraZeneca Pharmaceuticals, Waltham, Massachusetts.

Thomas R. Shryock, Ph.D.; Chief Scientific Officer and Managing Member, Antimicrobial Consultants L.L.C., Greenfield, Indiana.

Randall Singer, D.V.M., M.P.V.M., Ph.D.; Professor of Epidemiology, Department of Veterinary and Biomedical Sciences, St. Paul, Minnesota.

Robert A. Weinstein, M.D.; Former Chair, Department of Medicine, Cook County Health and Hospitals System, Chief Academic Officer, The C. Anderson Hedberg, M.D. Professor of Internal Medicine, Rush Medical College, Chicago.

 Top of Page